Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)

Melek BUYUK; Yasemin OZLUK; Dogu VURALLI BAKKALOGLU; Berker OZKAN; Pinar FIRAT; Dilek YILMAZBAYHAN

doi:10.5146/tjpath.2022.01593

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE)

Table of Contents

2023, Volume 39, Number 1, Page(s) 064-074

[ Abstract (English) ] [ Full Text (English) ] [ PDF ]

DOI: 10.5146/tjpath.2022.01593

Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)

Melek BUYUK¹, Yasemin OZLUK¹, Dogu VURALLI BAKKALOGLU¹, Berker OZKAN², Pinar FIRAT³, Dilek YILMAZBAYHAN¹

¹Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, ISTANBUL, TURKEY
²Department of Thoracic Surgery, Istanbul Faculty of Medicine, Istanbul University, ISTANBUL, TURKEY
³Department of Pathology, Koc University School of Medicine, ISTANBUL, TURKEY

[ Abstract (English) ] [ PDF ]